- October 8, 2023
- lifeschool22
Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP
Platforms
About Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP
Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP is a single player turn-based strategy game. It was developed by lifeschool22 and was released on October 8, 2023.
======================================= ++ BEAT CANCER AND EMPIRE PROTECTOR ++ ======================================= OPTIONS: * Select the difficulty and options before starting a new game by clicking with the mouse. * A light will highlight which options are active. * Then click the scenario to start a new game. AIMS: * Battle against Cancer or Ancient Enemies. * Move …
Games Like Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP
Looking for games like Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP? Here are top turn-based strategy recommendations, selected from player-similarity data — start with Beat Cancer and Empire Protector - Amiga OCS - Turn-based Action, Beat Cancer and Empire Protector (Amiga OS3) - Turn-based Action or The Great War: Western Front.
Frequently Asked Questions
Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP is a turn-based strategy game. Common tags for Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP include turn-based and war.
Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP is available on Amiga.
Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP was released on October 8, 2023.
Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP was developed by lifeschool22.
Beat Cancer and Empire Protector - Amiga OCS - Turn-based Strategy WIP is a single player game.
Similar games include Beat Cancer and Empire Protector - Amiga OCS - Turn-based Action, Beat Cancer and Empire Protector (Amiga OS3) - Turn-based Action, The Great War: Western Front, Ant Colony - Ants Simulator, FLERP and others.


















